CCND1 and cancer: Furthermore, the differential effect of SHetA2 on cancer over non-cancer tissues supports the potential of dietary doses below 250 mg/kg/day (1000 ppm) altering cyclin D1 in pre-cancerous and cancerous tissues, even though they did not reduce cyclin D1 protein in normal cervical tissue.